Currently Viewing:
Newsroom
Currently Reading
Researchers Demonstrate Efficacy of EEG-Based Test for Measuring Pain
December 07, 2018 – Alison Rodriguez
Patients Who Stop Taking Gilenya May Experience Worsening of Multiple Sclerosis
December 03, 2018 – Laura Joszt
Epigenetic Changes Are the Main Contributor to Immune Escape in Posttransplantation AML Relapse
November 30, 2018 – David Bai, PharmD
New, Nonopioid Pain Management Treatments Are Needed, Experts Say
November 30, 2018 – Alison Rodriguez
Back Pain Is Linked With Increased Risk of Death in Older Women
November 27, 2018 – Kelly Davio
FDA Approves 2 Treatments in Older Adults With Newly Diagnosed AML
November 26, 2018 – Laura Joszt
Advisory Committee Recommends Approval of Abuse-Deterrent MNK-812
November 22, 2018 – Kelly Davio
Co-occurrence of Certain Migraine Symptoms Indicates a Common Pathophysiology
November 21, 2018 – Laura Joszt
Early Data Suggests CC-486 Relatively Safe, Effective in Thrombocytopenic Patients With MDS
November 20, 2018 – Jackie Syrop

Researchers Demonstrate Efficacy of EEG-Based Test for Measuring Pain

Alison Rodriguez
Patients who visit the emergency department for pain are often asked to categorize their pain level using a visual scale of numbered faces. However, a recent study suggests the efficacy of a more empirical approach, through the use of an electroencephalography (EEG)-based test, that would be beneficial for both patients and physicians.
 
Patients who visit the emergency department for pain are often asked to categorize their pain level using a visual scale of numbered faces. However, a recent study suggests the efficacy of a more empirical approach, through the use of an electroencephalography (EEG)-based test, that would be beneficial for both patients and physicians.

The study, conducted by researchers at Brown University, evaluated the efficacy of the EEG test for preclinical screening in animals, with the use of 3 pain medications—Lyrica, an FDA-approved treatment for chronic pain; a pain medication in phase 2 clinical trials; and a medication with inconclusive efficacy based on previous studies. The test was intended to objectively measure pain by measuring brain activity with electrodes placed on the scalp, according to the researchers.

“More than 15% of adults in the United States suffer from chronic pain. Ineffective therapies and narrow therapeutic windows of available drugs are contributing to the opioid epidemic. The scant success rate of drug development is partly attributed to poor translatability of analgesic efficacy in pre-clinical models, which is based predominantly on behavioral assays,” explained the authors.

The researchers explained how pain and the effectiveness of pain medications in animals have previously been determined by poking an animal’s paw and measuring how quickly it moves its paws away—slower withdrawal is associated to less pain and more effective medication. The traditional test for animals, the EEG test, and the blood concentrations of the medications, were to the clinical blood concentration of the medications in human patients.

The results of the EEG demonstrated similar results for all 3 medications. Carl Saab, PhD, associate professor of neuroscience and neurosurgery at Brown University and Rhode Island Hospital and coauthor, noted that the EEG tested provided more accurate results with certain experiments, such as those involving a dose below the effective level of the first medication. Also, the EEG demonstrated a decrease in theta power measurement at the clinical dose but not the low dose, and the behavior test demonstrated slower paw withdrawal at the low dose and the clinical dose, according the research.

“Our goal is to associate specific brain activity with various scores on the numerical scale to make pain assessment more objective. We want to help patients with chronic pain and their physicians get into agreement about pain level so it is better managed and diagnosed, which may reduce the over-prescription of opioids,” Saab said in a statement.

The researchers suggest that these findings should be helpful in the development of more effective pain medications and for improving the diagnosis and management of chronic pain.

Reference

Koyama S, LeBlanc BW, Smith KA, et al. An electroencephalography bioassay for preclinical testing of analgesic efficacy. Scientific Reports. 2018;8(1). doi: 10.1038/s41598-018-34594-2.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up